2’-O-Methyl-guanosine 3-base RNA fragments mediate essential natural TLR7/8 antagonism

Author:

Alharbi Arwaf S.,Sapkota Sunil,Zhang Zhikuan,Jin Ruitao,Jayasekara W. Samantha N.,Rupasinghe Erandi,Speir Mary,Wilkinson-White Lorna,Gamsjaeger RolandORCID,Cubeddu Liza,Ellyard Julia I.,Wenholz Daniel S.,McAllan Alexandra L.,Rezwan Refaya,Ying Le,Far Hani Hosseini,Bones Josiah,He Sitong,Yu Dingyi,Lennox Kim A.,Hertzog Paul J.,Vinuesa Carola G.,Behlke Mark A.,Ohto Umeharu,Laczka Olivier F.,Corry Ben,Shimizu Toshiyuki,Gantier Michael P.ORCID

Abstract

AbstractRecognition of RNA fragments by Toll-like receptors (TLR) 7 and 8 is a key contributor to the initiation of a protective innate immune response against pathogens. A long-standing enigma is how degradation products of host RNAs, generated by the daily phagocytic clearance of billions of apoptotic cells, fail to activate TLR7 and TLR8 signalling1. Here, we report that select 2’-O-methyl (2’-Ome) guanosine RNA fragments as short as 3 bases, including those derived from host-RNAs, are potent TLR7 and TLR8 antagonists that reduce TLR7 sensingin vivo. Mechanistically, antagonistic fragments are directed towards a distinct binding site on these proteins by 5’-end 2’-Ome guanosine. Our results indicate that host-RNAs evade detection by TLR7/8 due to a pool of abundant host ribosomal 2’-Ome-modified RNA fragments that naturally antagonize TLR7 and TLR8 sensing to avoid auto-immunity. Crucially, rare TLR7 and TLR8 mutations located at this antagonistic site decrease the inhibitory activity of 2’-Ome guanosine RNA fragments and lead to auto-immunity in patients. Our findings also establish that select chemically synthesised 3-base oligonucleotides can harness the protective anti-inflammatory activity of this natural immune checkpoint for therapeutic targeting of TLR7-driven diseases.One Sentence SummaryShort 2’-O-Methyl RNA fragments are natural TLR7/8 antagonists

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3